September 2, 2015 | Teva Pharmaceutical Industries will begin to market ZECUITY, a patch system that provides relief from migraine headaches. The single-use, disposable patch will now be available by prescription in the United States. In order for it to work effectively, ZECUITY must be worn for four-hours on the upper arm or leg. Teva was founded in 1901 and is headed by CEO Erex Vigodman.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
UK Adopts Israeli Counter-Drone Technology
April 25, 2024
Top Tel Aviv Hospital Using AI In Neurological Therapy
April 18, 2024
Facebook comments